SGLT2 Inhibitors Progressing to New Standard After TAVI ...Middle East

Medscape - News
SGLT2 Inhibitors Progressing to New Standard After TAVI
In patients with heart failure, SGLT2 inhibitors after TAVI are associated with major risk reductions in a clinical trial that multiple experts are calling practice changing. Medscape Medical News

Hence then, the article about sglt2 inhibitors progressing to new standard after tavi was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SGLT2 Inhibitors Progressing to New Standard After TAVI )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News